Aster DM Healthcare Q4 Revenue Up 18% to ₹1,182 Cr

Aster DM Healthcare reported Q4 FY26 revenue growth of 18% YoY to ₹1,182 Cr with operating EBITDA (ex-Kasaragod) up 31% to ₹253 Cr.
The merger with Quality Care India Ltd received 96.68% shareholder approval and is expected to complete in Q1 FY27, creating a platform with over 10,623 beds.
Combined proforma performance showed revenue of ₹2,361 Cr (up 18% YoY) and operating EBITDA of ₹517 Cr (up 25% YoY) for the merged entity.
Strong operational performance driven by 15% patient volume growth, 9% increase in ARPP IP to ₹125,234, and margin expansion across hospital clusters.